Home The Word Brain	My Amedeo FAQ Privacy About
	Amedeo C49 English + 你好 (nǐ hǎo) = limitless possibilities. Start learning Mandarin Chinese today—for free, forever. Amedeo C49 is completely free, for life. Next week: +49.

Gastric Cancer

Free Subscription Articles published in Br J Surg Retrieve available abstracts of 27 articles: HTML format

Single Articles

March 2025
1. 
   Pathological response guides adjuvant 5-fluorouracil, leucovorin, oxaliplatin, and docetaxel (FLOT) chemotherapy in surgically resected gastro-oesophageal cancer (SPACE-FLOT): international cohort study.
   Br J Surg. 2025;112:znaf056.
   PubMed     Abstract available
   
   
   
2. VAN HOOTEGEM SJM, van der Linde M, Schneider MA, Kim J, et al
   Impact of postoperative complications on clinical outcomes after gastrectomy for cancer: multicentre study.
   Br J Surg. 2025;112:znaf043.
   PubMed     Abstract available
   
   
   November 2024
3. BYRNE BE, Siaw-Acheampong K, Evans O, Taylor J, et al
   REsolution of Symptoms afTer Oesophago-gastric cancer REsection delphi (RESTOREd)-standardizing the definition, investigation and management of gastrointestinal symptoms and conditions after surgery.
   Br J Surg. 2024;111:znae286.
   PubMed     Abstract available
   
   
   October 2024
4. WALKER RC, Barman S, Pucher PH, Singh P, et al
   Association of Upper Gastrointestinal Surgery of Great Britain and Ireland (AUGIS)/perioperative quality initiative (POQI) consensus statement on prehabilitation in oesophagogastric surgery.
   Br J Surg. 2024;111:znae223.
   PubMed     Abstract available
   
   
   July 2024
5. BRANDL A, van Sandick JW
   Treatment of gastric cancer peritoneal metastases: role of cytoreductive surgery and hyperthermic intraperitoneal chemotherapy.
   Br J Surg. 2024;111:znae149.
   PubMed    
   
   
   
6. XIE D, Shen J, Gong J
   Author response to: Comment on: Randomized clinical trial on D2 lymphadenectomy versus D2 lymphadenectomy plus complete mesogastric excision in patients undergoing gastrectomy for cancer (DCGC01 study).
   Br J Surg. 2024;111:znae157.
   PubMed    
   
   
   
7. LIANG X, Wu J, Yu H
   Comment on: Randomized clinical trial on D2 lymphadenectomy versus D2 lymphadenectomy plus complete mesogastric excision in patients undergoing gastrectomy for cancer (DCGC01 study).
   Br J Surg. 2024;111:znae156.
   PubMed    
   
   
   
8. BROWN LR, Crumley AB, Skipworth RJE
   Author response to: Comment on: Cachexia index for prognostication in surgical patients with locally advanced oesophageal or gastric cancer: multicentre cohort study.
   Br J Surg. 2024;111:znae173.
   PubMed    
   
   
   
9. ARKLE TS, Sivarajan SG, Penney NC, Rafiee H, et al
   Comment on: Cachexia index for prognostication in surgical patients with locally advanced oesophageal or gastric cancer: multicentre cohort study.
   Br J Surg. 2024;111:znae172.
   PubMed    
   
   
   June 2024
10. ZHANG W, Huang J
    Comment on: Randomized clinical trial on D2 lymphadenectomy versus D2 lymphadenectomy plus complete mesogastric excision in patients undergoing gastrectomy for cancer (DCGC01 study).
    Br J Surg. 2024;111:znae145.
    PubMed    
    
    
    
11. XIE D, Shen J, Gong J
    Author response to: Comment on: Randomized clinical trial on D2 lymphadenectomy versus D2 lymphadenectomy plus complete mesogastric excision in patients undergoing gastrectomy for cancer (DCGC01 study).
    Br J Surg. 2024;111:znae146.
    PubMed    
    
    
    May 2024
12. ZAFFARONI G, Mannucci A, Koskenvuo L, de Lacy B, et al
    Updated European guidelines for clinical management of familial adenomatous polyposis (FAP), MUTYH-associated polyposis (MAP), gastric adenocarcinoma, proximal polyposis of the stomach (GAPPS) and other rare adenomatous polyposis syndromes: a joint EH
    Br J Surg. 2024;111:znae070.
    PubMed     Abstract available
    
    
    
13. GUCHELAAR NAD, Nasserinejad K, Mostert B, Koolen SLW, et al
    Intraperitoneal chemotherapy for peritoneal metastases of gastric origin: a systematic review and meta-analysis.
    Br J Surg. 2024;111:znae116.
    PubMed     Abstract available
    
    
    
14. XIE D, Shen J, Liu L, Cao B, et al
    Randomized clinical trial on D2 lymphadenectomy versus D2 lymphadenectomy plus complete mesogastric excision in patients undergoing gastrectomy for cancer (DCGC01 study).
    Br J Surg. 2024;111:znae106.
    PubMed     Abstract available
    
    
    
15. LI K, Leng X, Han Y, Peng L, et al
    Comment on: Cachexia index for prognostication in surgical patients with locally advanced oesophageal or gastric cancer: multicentre cohort study.
    Br J Surg. 2024;111:znae136.
    PubMed    
    
    
    
16. BROWN LR, Crumley AB, Skipworth RJE
    Author response to: Comment on: Cachexia index for prognostication in surgical patients with locally advanced oesophageal or gastric cancer: multicentre cohort study.
    Br J Surg. 2024;111:znae135.
    PubMed    
    
    
    April 2024
17. BROWN LR, Thomson GG, Gardner E, Chien S, et al
    Cachexia index for prognostication in surgical patients with locally advanced oesophageal or gastric cancer: multicentre cohort study.
    Br J Surg. 2024;111:znae098.
    PubMed     Abstract available
    
    
    
18. SCHNEIDER MA, Gutschow CA
    Author response to: Comment on: Defining benchmarks for total and distal gastrectomy: global multicentre analysis.
    Br J Surg. 2024;111:znae079.
    PubMed    
    
    
    January 2024
19. LIU W, Chen X, Zhou Z, Chen Y, et al
    Reinforcement of the stapled duodenal stump during laparoscopic gastrectomy.
    Br J Surg. 2024;111:znad305.
    PubMed    
    
    
    
20. 
    Erratum to: Long-term oncological outcomes of robotic versus laparoscopic gastrectomy for gastric cancer: multicentre cohort study.
    Br J Surg. 2024;111:znae025.
    PubMed    
    
    
    
21. SCHNEIDER MA, Kim J, Berlth F, Sugita Y, et al
    Defining benchmarks for total and distal gastrectomy: global multicentre analysis.
    Br J Surg. 2024;111:znad379.
    PubMed    
    
    
    
22. LI ZY, Wei B, Zhou YB, Li TY, et al
    Long-term oncological outcomes of robotic versus laparoscopic gastrectomy for gastric cancer: multicentre cohort study.
    Br J Surg. 2024;111:znad435.
    PubMed     Abstract available
    
    
    September 2023
23. BAUSYS A, Luksta M, Anglickiene G, Maneikiene VV, et al
    Effect of home-based prehabilitation on postoperative complications after surgery for gastric cancer: randomized clinical trial.
    Br J Surg. 2023 Sep 26:znad312. doi: 10.1093.
    PubMed     Abstract available
    
    
    June 2023
24. MARKAR SR, Guazzelli A, Taylor A, Jones LL, et al
    Protocol for open-label randomized clinical trial of intensive surveillance versus standard postoperative follow-up in patients undergoing surgical resection for oesophageal and gastric cancer.
    Br J Surg. 2023 Jun 28:znad180. doi: 10.1093.
    PubMed    
    
    
    
25. VAN DIEREN JM, van der Post RS, Bisseling TM
    Shifting perceptions on endoscopic surveillance and timing of prophylactic gastrectomy for hereditary diffuse gastric cancer.
    Br J Surg. 2023 Jun 24:znad192. doi: 10.1093.
    PubMed    
    
    
    March 2023
26. BAXTER MA, Khan KS, Gall LS, Samuelson C, et al
    Diagnosis, treatment, and outcome of patients with oesophagogastric cancer during the COVID-19 pandemic: national study.
    Br J Surg. 2023;110:456-461.
    PubMed     Abstract available
    
    
    
27. PUCHER PH, Park MH, Cromwell DA, Crosby TC, et al
    Diagnosis and treatment for gastro-oesophageal cancer in England and Wales: analysis of the National Oesophago-Gastric Cancer Audit (NOGCA) database 2012-2020.
    Br J Surg. 2023 Mar 27:znad065. doi: 10.1093.
    PubMed     Abstract available
    
    

Thank you for your interest in scientific medicine.

AMEDEO Gastric Cancer is free of charge.